1. Mullen L, Richardson C, Gardner A, Jones T, Tolley C. 458 Medicines management of long-term conditions during the COVID-19 pandemic: a narrative systematic review. Int J Pharm Pract. 2023;31(Supplement_1): i14-i15. doi:10.1093/ijpp/riad021.016
2. Grad R, Ebell MH. Top 20 research studies of 2023 for primary care physicians. Am Fam Physician. 2024;110(1):65-73.
3. World Health Organization. COVID-19 weekly epidemiological update, edition 134, 16 March 2023.
4. Swank Z, Senussi Y, Manickas-Hill Z, et al. Persistent circulating severe acute respiratory syndrome Coronavirus 2 spike is associated with post-acute Coronavirus disease 2019 sequelae. Clin Infect Dis. 2023; 76(3):e487-e490. doi:10.1093/cid/ciac722
5. Mageriu V, Zurac S, Bastian A, Staniceanu F, Manole E. Histological findings in skeletal muscle of SARS-CoV2 infected patient. J Immunoassay Immunochem. 2020;41(6):1000-1009. doi:10.1080/15321819. 2020.1863819
6. Buonsenso D, Martino L, Morello R, Mariani F, Fearnley K, Valentini P. Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies. Lancet Microbe. 2023;4(9): e745-e756. doi:10.1016/s2666-5247(23)00115-5
7. Murat S, Dogruoz Karatekin B, Icagasioglu A, Ulasoglu C, İçten S, Incealtin O. Clinical presentations of pain in patients with COVID-19 infection. Irish J Med Sci (1971). 2021;190(3):913-917. doi:10.1007/s11845- 020-02433-x
8. Su S, Cui H, Wang T, Shen X, Ma C. Pain: a potential new label of COVID-19. Brain Behav Immun. 2020;87:159-160. doi:10.1016/j.bbi. 2020. 05.025
9. Attal N, Martinez V, Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic.Pain Rep. 2021;6(1): e884. doi:10.1097/PR9.0000000000000884
10. Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurology. 2011;11(1):37. doi: 10.1186/1471-2377-11-37
11. Stainsby B, Howitt S, Porr J. Neuromusculoskeletal disorders following SARS: a case series. J Can Chiropr Assoc. Mar 2011;55(1):32-39.
12. Bozdağ F, Ergün N. Psychological resilience of healthcare professionals during COVID-19 pandemic.Psychol Rep. 2021;124(6):2567-2586. doi:10.1177/0033294120965477
13. World Health Organization clinical management of COVID-19: interim guidance 27 may 2020. World Health Organization. 2020.
14. Fadhil M, Singh R, Havas T, Jacobson I. Systematic review of head and neck lymphedema assessment. Head Neck. 2022;44(10):2301-2315. doi: 10.1002/hed.27136
15. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2): 29-36. doi:10.1016/j.pain.2004.12.010
16. Macdonald N. Canada and the WHO cancer pain relief program. J Palliat Care. 1986;1(2):31.
17. Fairbank JC, Couper J, Davies JB, O’Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66(8):271-273.
18. Buscemi V, Chang WJ, Liston MB, McAuley JH, Schabrun SM. The role of perceived stress and life stressors in the development of chronic musculoskeletal pain disorders: a systematic review. J Pain. 2019;20(10): 1127-1139. doi:10.1016/j.jpain.2019.02.008
19. Wei JT, Liu ZD, Fan ZW, Zhao L, Cao WC. Epidemiology of and risk factors for COVID-19 infection among health care workers: a multi-centre comparative study. Int J Environ Res Public Health. 2020;17(19): 7149. doi:10.3390/ijerph17197149
20. Ciaffi J, Vanni E, Mancarella L, et al. Post-acute COVID-19 joint pain and new onset of rheumatic musculoskeletal diseases: a systematic review. Diagnostics. 2023;13(11):1850. doi:10.3390/diagnostics13111850
21. El-Tallawy SN, Perglozzi JV, Ahmed RS, et al. Pain management in the post-COVID era-an update: a narrative review. Pain Therapy. 2023; 12(2):423-448. doi:10.1007/s40122-023-00486-1
22. Fernández-De-Las-Peñas C, Navarro-Santana M, Plaza-Manzano G, Palacios-Ceña D, Arendt-Nielsen L. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome Coronavirus 2 infection: a systematic review and meta-analysis. Pain. 2022;163(7):1220-1231. doi: 10.1097/j.pain.0000000000002496
23. O’Sullivan G, Jacob S, Barrett PM, Gallagher J. COVID-19 presentation among symptomatic healthcare workers in Ireland. Occupat Med. 2021; 71(2):95-98. doi:10.1093/occmed/kqab012
24. Lan F-Y, Filler R, Mathew S, et al. COVID-19 symptoms predictive of healthcare workers’ SARS-CoV-2 PCR results. PLoS One. 2020;15(6): e0235460. doi:10.1371/journal.pone.0235460
25. AlOmar RS. Levels of physical activity and prevalence of musculoskeletal disorders among physicians in Saudi Arabia post COVID-19 lockdown: an epidemiological cross-sectional analysis. J Prim Care Community Health. 2021;12:21501327211040359. doi:10.1177/ 21501327211040359
26. Lim SH, Lim YC, Zaki RA, et al. Prevalence and predictors of post-acute COVID syndrome among infected healthcare workers at University Malaya Medical Centre. PLoS One. 2024;19(4):e0298376. doi:10.1371/journal.pone.0298376
27. Madani TA, Al-Abdullah NA, Binmahfooz SM, et al. COVID-19 infections among health care workers at a university hospital in Jeddah, Saudi Arabia. Am J Infect Control. 2024;52(11):1258-1262. doi:10.1016/j.ajic.2024.06.022
28. Arca M, Dönmezdil S, Durmaz ED. The effect of the COVID-19 pandemic on anxiety, depression, and musculoskeletal system complaints in healthcare workers. Work. 2021;69(1):47-54. doi:10.3233/wor-205014
29. Ateş R, Yakut H. Investigation of musculoskeletal disorders, physical activity level, sleep quality, and fatigue in health professionals with and without a history of COVID-19. Work. 2023;74(4):1277-1287. doi:10. 3233/wor-220283
30. Buonafine CP, Paiatto BNM, Leal FB, et al. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil. BMC Infect Dis. 2020; 20(1):917. doi:10.1186/s12879-020-05662-8
31. Magdy R, Eid RA, Fathy W, et al. Characteristics and risk factors of persistent neuropathic pain in recovered COVID-19 patients. Pain Med. 2022;23(4):774-781. doi:10.1093/pm/pnab341